Additionally, Mr. Balakrishnan held the position of Director at Ishaanav Nutraceuticals in India, a Contract Manufacturing Organization (CMO) specializing in Nutraceuticals. Currently, he serves as the CEO and Director of Amdis Health Sciences in India. Simultaneously, he holds the position of Managing Director at Aurora Farmabio in India, where he oversees Business-to-Business (B2B) activities with a focus on Contract Development and Manufacturing Organization (CDMO) services. His responsibilities extend to licensing both in and out of functional ingredients, as well as handling Niche Active Pharmaceutical Ingredients (APIs) for both Indian and Global markets.

Moreover, he significantly raised Vitamin D awareness in the UAE and GCC, introducing the Vita D range, Sundrops and Ultra D range. In Gastroenterology, he also launched products like Esoxx, Flatuna, Medirefleux and Simecol across the GCC.

Recognizing nutritional gaps, he introduced successful brands like Heme Bears, Mg Vita, and Globifer Forte. Focusing on OTC opportunities, he launched well-received brands like Oraheal, Privituss, and Camdol Range. At Microsynergy Pharmaceuticals, UAE, Mr. Balakrishnan introduced blockbuster Pain and Allergy management brands, including Coxib, Hicet Erostin, Carmellose HA and Serrodase. The success of Fosmol and Tafixyl brands established Microsynergy as a formidable presence in the Gynec and Urology segment. Played a key role in the strategic decision to form a manufacturing facility in Dubai, significantly enhancing the scalability of Microsynergy’s pharmaceutical business.